Foot osteoarthritis (OA) is a very common disease that mainly affects older people deeply influencing their quality of life. The joint most frequently involved in the articular degenerative process is the first metatarsophalangeal joint. Its severe impairment may lead to a specific clinical pattern known as hallux rigidus that often requires surgical treatment. Currently conventional radiograms of feet associated with an accurate clinical examination should be performed in order to diagnose foot OA. However, new imaging modalities as ultrasonography and magnetic resonance imaging are emerging as valuable tools to assess foot OA. Therapeutic options for foot OA consist of conservative strategies, including life-style modification and pharmacological treatment, options that are usually adopted in early-stage disease and in invasive surgical procedures reserved to late-stage conditions. At the present time there is a lack of evidence in international literature specifically dealing with foot OA, so further investigation on this topic is required to clarify its pathogenesis, the diagnostic pathway and the best clinical management.
Osteoarthritis (OA) is a degenerative disorder that results from the biochemical breakdown of articular cartilage in the synovial joints and is the commonest cause of arthritis and a leading cause of pain and disability worldwide [1] .
Biomechanical and biochemical factors, such as the production of several chemokines, cytokines, and growth factors, determine an aberrant chondrocyte activation that contributes to the disruption of articular homeostasis. The imbalance between pro-and anti-inflammatory molecules may influence the progression of cartilage damage [2] .
OA accounts for 15% of all musculoskeletal consultations in patients aged 45 years and over in primary care [3] . This degenerative articular disease predominantly affects the knees, hips, hands and feet. Whereas the knee, the hip and the hand have received considerable attention, the foot has been relatively neglected yet the first metatarsophalangeal joint is one of the joints most frequently affected by OA [4] .
The aim of this review is to provide an overview of the current knowledge on foot OA, concerning risk factors, clinical features, diagnosis and treatment.
Epidemiology and pathomechanism
OA is the leading cause of chronic pain and disability among older people in developed countries. A podiatric supplement to the US National Health Interview Survey estimated that 24% of the population has at least one foot ailment, with older adults experiencing more troubles than younger adults [5] . Recent prevalence data from the Framingham Study reported that 19% of men and 29% of women reported foot pain on most days of the month, with prevalence of pain at specific foot locations ranging from 7% to 13% [6] .
The foot is involved with a variable frequency according to the joint sites, hindfoot OA is quite uncommon, but forefoot OA is a frequent joint disease, particularly at the level of the first metatarsophalangeal joint, that represents the prime site of OA changes. It is estimated that OA of the big toe joint affects 35% to 60% of adults aged over 65 years [7] .
The midfoot is rarely involved in OA alterations and only few research groups have described non-Charcot arthropathy of the midfoot, including patients with primary OA in this joint site [8] [9] [10] .
The literature suggests that midfoot OA is usually post-traumatic. Midfoot injuries affect approximately 55,000 people per year and are commonly seen in the athletic population [11] . Despite their seemingly low incidence, they are particularly important because as many as 20% are missed or misdiagnosed [12] .
Moreover OA of the tarsometatarsal joints has emerged as a challenging problem due to its high potential for foot pain and chronic secondary disability. In fact subjects with midfoot OA experience foot pain which deeply limits their participation in walking and weightbearing activities.
The etiology of foot OA is still poorly understood, in fact only a few studies in international literature have highlighted major risk factors for developing foot OA [13, [16] [17] [18] [19] [20] [21] . It has been linked to trauma, sport injuries, inflammatory arthropathy, mechanical stress and idiopathic osteoarthritis [13] . Several authors have suggested that, similarly to other forms of non-traumatic OA, foot OA may be a result of abnormally high mechanical stress due to abnormal structural factors [14, 15] . Davitt et al. hypothesized that aberrant loading may be the result of toe length abnormalities, as patients with idiopathic midfoot OA were more likely to have a second toe longer than the great toe [16] . OA of the first metatarsophalangeal joint of the foot, commonly referred to as hallux limitus or hallux rigidus, is thought to be caused by the compression of the dorsal aspect of the joint during the propulsive phase of gait in people with an excessively wide first metatarsal, wide proximal phalanx and long sesamoids. Furthermore people with flat feet or high arches are at greater risk for developing foot OA. A recent research has indicated that older people with radio-graphically-confirmed OA of the talonavicular joint and navicular-first cuneiform joint have significantly flatter feet in association with a significant greater dynamic loading of the midfoot when walking [17] [18] [19] [20] . Finally, Yu et al suggested that the aberrant loading may be a result of past shoe use or footwear, noting that chronic high-heel use increased the risk of midfoot OA [21] .
In addition, general factors as aging and obesity seem to play a key role in the pathomechanism of OA. Aging determines the reduction of cartilage volume, proteoglycan content, cartilage vascularization, and cartilage perfusion leading to favorable conditions to initiate the OA process. Obesity increases the mechanical stress in weight-bearing joints, so it particularly affects lower limb joints. Furthermore it has been demonstrated that obese patients alter their movement strategies of every day movements causing important changes in joint biomechanics. Both factors contribute to the degenerative process that involves joint cartilage [22] [23] [24] .
Clinical features
The key feature of OA is the progressive destruction of joint cartilage that causes reduction of articular space, subcondral sclerosis, subcondral cysts, synovial phlogosis and osteophyte formation.
The usual symptoms associated with foot OA include: pain and stiffness of the affected foot, swelling near the affected joint, limited range of motion, difficulty in walking and bony protrusions. There are 28 bones and more than 30 joints in the human foot. The foot joints that are most commonly affected by osteoarthritis include:
• the 3 joints of the hindfoot (talocalcaneal joint, talonavicular joint, calcaneocuboid joint) • the midfoot (metatarsocuneiform joint) • the great toe (first metatarsophalangeal joint) OA releated pain diminishes the quality of life and limits physical functions. Patients have problem in doing housework as well as leisure activities [25, 26] . In addition severe OA leads to deformities that typically affect the metatarsophalangeal joint causing significant limitation of motion and function of feet [27] . Structural alterations of the first metatarsophalangeal joint are described as either hallux limitus or hallux rigidus. The term used depends on the magnitude of available joint motion and the severity of joint degeneration. Hallux limitus is characterized by restricted sagittal plane motion (primarily dorsiflexion) caused by periarticular osteophytes; whereas hallux rigidus displays an absence of joint motion due to end stage degenerative joint disease and subsequent joint ankylosis. Although the terms are often used interchangeably, hallux rigidus has been adopted by the World Health Organization in the International Classification of Diseases [28, 29] .
Foot joints can even be affected by a rare form of OA that is characterized by erosions. Erosive OA has a poor clinical outcome. Patients experience several inflamma-tory episodes due to cartilage debris that activate the inflammatory process resulting in progressive joint damage and structural change [30] .
Diagnosis
Physical examination can detect swelling, bone spurs or other deformities, limited range of motion and pain which occurs with movement. However, to define the diagnosis conventional radiographs are required to assess typical alterations found in foot OA joints.
Different radiographic scales to identify and quantify foot OA exist, but the most frequently used is the one elaborated by Kellgren and Lawrence. This scale ranges from 0 to 4: 0 corresponding to absence of OA features and 4 to severe OA.
The radiological features usually examined are:
1) The formation of osteophytes on the joint margins or, in the case of the knee joint, on the tibial spines.
2) Periarticular ossicles; in particular at the level of distal and proximal interphalangeal joints.
3) Narrowing of joint cartilage associated with sclerosis of subchondral bone.
4) Small pseudocystic areas with sclerotic walls situated usually in the subchondral bone. 5) Altered shape of the bone ends, particularly in the head of femur [31] .
In 2007 Menz at al [32] presented an atlas of radiographic features of OA in commonly affected joints of the foot based on observations of osteophytes and joint space narrowing. The aim was to standardize the documentation and interpretation of foot OA for epidemiological studies and clinical trials. Authors suggested a foot radiography protocol to identify OA. According to them weight-bearing dorso-plantar and lateral radiographic projections have to be performed in order to document osteophytes and joint space narrowing from both, in fact it was evident that the dorso-plantar projection provided the greatest clarity for some joints, whereas the lateral projection was the most suitable for others. The atlas was demonstrated to be acceptably reliable, and considered useful to document features in individual joints or to calculate a global foot OA score [32] . Recently many researchers have described the importance of ultrasonography (US) in evaluating joints and periarticular structures [33] . In the past decades the impressing technological development of US machines has encouraged the application of US in rheumatological clinical practice as a sensitive and bedside imaging technique. It has even been included in the classification criteria for polymyalgia rheumatica in 2012 [33] [34] [35] . US, differently from radiography, can detect inflammation, cartilage reduction and even early erosions. The existing literature dealing with the ultrasonographic assessment of foot has focused on several rheumatic diseases as gout, early arthritis, rheumatoid arthritis and psoriatic arthritis [36] [37] [38] [39] [40] . However, even if US has been depicted as a valuable tool to assess the severity of osteoarthritic lesions and to accurately monitor their eventual progression, currently there is only one article that deals with the application of US in foot OA [41] . In this study bilateral US of the midfoot and forefoot joints was performed assessing both inflammatory (joint effusion, synovial hypertrophy, local pathologic vascularization at Power Doppler, big toe bursitis) and structural (osteophytes, metatarsophalangeal joints subluxation) abnormalities. Authors concluded that US was a useful imaging technique for analysing both inflammatory and structural damage lesions at foot joints level in OA. In addition, it was demonstrated to be more sensitive than clinical examination in the detection of inflammatory abnormalities [42] .
Finally, clinicians should consider magnetic resonance imaging (MRI) too. MRI-based research is becoming increasingly more common in the OA research community. Novel MRI-based semiquantitative scoring systems have been proposed for the knee, hip and hand OA. MRI identifies earlier changes in OA joints compared to standard radiography. A systematic review published in 2011 examined the validity of MRI in OA and authors concluded that MRI is the current most valuable imaging tool for the assessment of OA due to its unique ability to visualize multiple individual tissue pathologies relevant in regard to pain and other clinical outcomes. In fact, MRI is able to detect bone marrow lesions, synovitis and effusion that have been related to pain. On the basis of these results, MRI is now recommended for clinical trials in terms of cartilage morphology assessment [43] [44] [45] .
Recent studies have focused their attention on the delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC). Thanks to this particular technique it is possible to estimate the cartilage glycosaminoglican (GAG) content. It seems to be a promising and sensitive biomarker to reveal degenerative modifications in cartilage quality in the very early stages of OA [46] .
Treatment
Therapeutic strategies for foot OA are based on a wide spectrum of options and need to be always patient oriented. Treatment decisions should be made according to a staged approach. Conservative treatment should be advised in early OA while more invasive procedures particular the international research is focused in the treatment of OA of the big toe. A systematic review published in 2010 described surgical options to treat hallux rigidus and/or limitus. Procedures include cheilectomy (removal of a bony lump at the joint margin), arthrodesis (surgical fusion of bones), arthroplasty (joint replacement via remodelling or implant), osteotomy (cutting bone to shorten, lengthen or realign), soft tissue release and sesamoid release or excision [57] [58] [59] .
Conclusions
Foot OA is a common musculoskeletal disorder that particularly affects older people worsening their quality of life. The joint most frequently involved in the degenerative progression of OA is the first metatarsophalangeal one. The pathogenesis and risk factors for foot OA need to be further investigated. US and MRI are gaining importance in the diagnostic pathway of OA, even if conventional radiology must still be referred as the "gold standard" imaging technique. Therapeutic strategy for foot OA, involving conservative and invasive treatments, should always be related to the OA stage in the single patient. New researches dealing with the treatment of foot OA are required in order to make the best decisions for the management of this articular degenerative disease.
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should be considered when symptoms and deformities become unbearable and deeply affect the patient's quality of life.
Conservative therapy Weight-loss is often proposed as an important endpoint to reduce foot pain. However only few studies have investigated the role of weight loss in improving foot OA related pain, so current evidence dealing with this topic is still too limited [22] .
Exercise has been proven to be a protective factor against OA as it stimulates biosynthetic activity of chondrocytes. However, excessive physical exercise can damage the articular and periarticular structures. So, patients with OA capable of exercise should be encouraged to partake in a low-impact aerobic exercise program (walking, biking, swimming or other aquatic exercise) [47, 48] .
Furthermore, two studies in literature have demonstrated how orthotic treatment for midfoot OA significantly decreases pain levels, increases activity levels and footwear comfort [49, 50] .
As pharmacological options, chondroprotective agents and analgesics should be used.
Different studies have evaluated in randomized controlled trials and systematic reviews the effect of glucosamine, chondroitin sulfate and collagen derivatives in blocking the progression of cartilage denaturation in OA. The results showed a global beneficial trend even if compared with placebo, glucosamine, chondroitin, and their combination did not significantly reduce joint pain or have an impact on the narrowing of joint space [51, 52] .
The analgesic therapy recommended for the initial management of patients with OA includes acetaminophen, oral and topical non-steroidal anti-inflammatory drugs, tramadol, and intra-articular corticosteroid injections; while intra-articular hyaluronate injections, duloxetine, and opioids are conditionally recommended in patients who have an inadequate response to initial therapy. Opioid analgesics are strongly recommended in patients who cannot undergo surgical treatment, as total joint arthroplasty, after having failed medical therapy [53] .
Recently there has been an important increase of interest in intra-articular application of hyaluronic acid to treat OA joints. Hyaluronic acid provides viscosupplementation in order to restore the viscosity and elasticity of synovial fluid. Its efficacy has been demonstrated in knee, hip and ankle OA. There is a lack of data concerning hyaluronic intra-articular injections on foot joints [54] [55] [56] .
Surgery In cases of severe deforming foot OA, surgery should be considered as an endpoint therapeutic approach. In
